Double-blind, placebo-controlled, crossover trial of MK 0893 to assess recovery from hyperglycaemia in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 28 Jun 2011
At a glance
- Drugs MK 0893 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
- 28 Jun 2011 New trial record